SCHEMBL125055

SCHEMBL125055

[CH2]CCC(C)(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3161986 0.80
SCHEMBL2307954 0.79
SCHEMBL3166953 0.78
SCHEMBL37987 0.76 ALDH1A1 (1.00)
SCHEMBL15512260 0.76
SCHEMBL20378020 0.76 ALDH1A1 (0.47)
SCHEMBL45262 0.74
SCHEMBL1222550 0.73
SCHEMBL97628 0.72
Ammonia Solution, Strong SCHEMBL28802926 0.72 ALDH1A1 (0.91)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116496256-A Carbonyl bridged heterocyclic compound, and composition and application thereof 北京赛特明强医药科技有限公司 2023-07-28 CN claimed
WO-2023131116-A1 CARBONYL BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2023-07-13 WO claimed
CN-116143692-A Compounds, products and methods for determining the content or presence of vitamin D 科美博阳诊断技术(上海)有限公司 2023-05-23 CN claimed
WO-2023068322-A1 CD RING SIDE CHAIN-SUBSTITUTED VITAMIN D DERIVATIVE 学校法人帝京大学 2023-04-27 WO claimed
CN-115850141-A Intermediate compound and preparation method and application thereof 科美博阳诊断技术(上海)有限公司 2023-03-28 CN claimed
CN-111518005-A Intermediate compound and preparation method and application thereof 博阳生物科技(上海)有限公司 2020-08-11 CN claimed
CN-111518008-A Compounds, products and methods for determining the content or presence of vitamin D 博阳生物科技(上海)有限公司 2020-08-11 CN claimed
WO-2019199137-A1 METHOD FOR IMPROVING PROPERTIES OF SEPARATOR THROUGH POST-TREATMENT CROSSLINKING AND SEPARATOR THEREBY 주식회사 엘지화학 2019-10-17 WO claimed
US-20190225396-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION SYMRISE AG (DE) 2019-07-25 US claimed
EP-3507352-A1 PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION Symrise AG (DE) 2019-07-10 EP claimed
EP-0521550-B1 Vitamin D compound, method of preparing this compound and intermediate therefor DUPHAR INT RES (NL) 1996-09-18 EP claimed
EP-0344288-B1 METHOD OF INHIBITING THE ACTIVITY OF LEUKOCYTE DERIVED CYTOKINES HOECHST ROUSSEL PHARMA (US) 1995-02-15 EP claimed
EP-0521550-A2 Vitamin D compound, method of preparing this compound and intermediate therefor DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1993-01-07 EP claimed
EP-0344288-A4 METHOD OF INHIBITING THE ACTIVITY OF LEUKOCYTE DERIVED CYTOKINES 1992-01-15 EP claimed
US-4956374-A BACTERICIDES, CANDIDA BRISTOL-MYERS COMPANY (US) 1990-09-11 US claimed
EP-0375757-A1 COMPOUNDS EFFECTIVE IN INDUCING CELL DIFFERENTIATION WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1990-07-04 EP claimed
US-4927815-A HOMOLOGS OF 1,25-DIHYDROXYVITAMIN D3 AS AGENTS FOR THE TREATMENT OF NEOPLASTIC DISEASES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1990-05-22 US claimed
EP-0344288-A1 METHOD OF INHIBITING THE ACTIVITY OF LEUKOCYTE DERIVED CYTOKINES HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-12-06 EP claimed
WO-1989010353-A1 COMPOUNDS EFFECTIVE IN INDUCING CELL DIFFERENTIATION WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1989-11-02 WO claimed
WO-1989005145-A1 METHOD OF INHIBITING THE ACTIVITY OF LEUKOCYTE DERIVED CYTOKINES HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-06-15 WO claimed